LOAN MODIFICATION AGREEMENTLoan Modification Agreement • May 10th, 2004 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledMay 10th, 2004 Company IndustryThis Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of April 7, 2004, by and between SILICON VALLEY BANK, a California-chartered bank, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts 02462, doing business under the name “Silicon Valley East” (“Bank”) and GTC BIOTHERAPEUTICS, INC., a Massachusetts corporation with its chief executive office located at 175 Crossing Boulevard, Suite 410, Framingham, Massachusetts 01702 (“Borrower”).
LOAN MODIFICATION AGREEMENTLoan Modification Agreement • May 10th, 2004 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledMay 10th, 2004 Company IndustryThis Loan Modification Agreement (this “Loan Modification Agreement’) is entered into as of January 25, 2004, by and between SILICON VALLEY BANK, a California-chartered bank, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts 02462, doing business under the name “Silicon Valley East” (“Bank”) and GTC BIOTHERAPEUTICS, INC., a Massachusetts corporation with its chief executive office located at 175 Crossing Boulevard, Suite 410, Framingham, Massachusetts 01702 (“Borrower”).